ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2126

STAT4 Activation By Type I Interferons Regulates Pathogenic IL-21 and IFN-γ in Lupus

Xuemei Dong1, Fotios Koumpouras2, Joseph E. Craft3 and Jason Weinstein1, 1Rheumatology, Yale University School of Medicine, New Haven, CT, 2Internal Medicine, Rheumatology, Yale University School of Medicine, New Haven, CT, 3Department of Internal Medicine/Rheumatology, Yale University School of Medicine, New Haven, CT

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: cytokines, interferons and pathogenesis, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Follicular helper T cells (Tfh) cells in lupus help shape the germinal center (GC) response by delivering contact-dependent and soluble signals, including the cytokines IFN-γ and IL-21. In conventional immune responses, synthesis of Tfh-cell cytokines is regulated by the transcription factors STAT4, T-bet, and Bcl6, although their regulation in lupus is not known. To answer this question, we examined the differential expression of these transcription factors in splenic Tfh cells prior to onset of disease, after immune cell activation but before end organ disease onset, and then in later severe disease in lupus-prone B6.Sle1.Yaa mice. We also assess applicability to human lupus.

Methods: Spleens were harvested from 2,4 and 6 months old B6.Sle1.Yaa mice. Transcription factor (T-bet and Bcl6) and cytokine production were assessed by intercellular flow cytometry. Cell were stimulated with PMA and ionomycin, and Tfh (CD4+CD44hiLy6cloPSGL-1loCXCR5hiPD-1hi) and Th1 (CD4+CD44hiLy6chiPSGL-1hi) cells were stained for IL-21 and IFN-γ. Phosphorylation STAT4 in Tfh and Th1 cells were analyzed by flow cytometry after stimulation by IFN-α or IL-12 for 20 minutes in DMEM medium with 1% serum.

Twenty-eight SLE patients from age 18 to 75 years and twenty age-matched healthy control were enrolled in this study. All SLE patients had fulfilled the revised disease criteria of the American College of Rheumatology 1997. Disease activity was assessed with the SLE Disease Activity Index 2000 (SLEDAI2K). Mononuclear cells from the peripheral blood samples were isolated using Ficoll-Paque density gradient media and rested suspended in DMEM medium with 10% serum overnight. Phosphorylation STAT4 in circulating Follicular helper-like T cells (CD4+CD45RA–CXCR5hiPD1hiCCR7lo) and CD4+ T memory cells (CD4+CD45RA–CXCR5hiPD1loCCR7hi) were analyzed by flow cytometry after stimulation by IFN- α or IL-12 for 20 minutes in DMEM medium with 1% serum.

Results: We determined that GC Tfh cells produced IL-21 and IFN-γ at similar rates during these three stages of disease; however, Tfh-cell STAT4 activity increased while Bcl6 and T-bet expression declined as disease progressed, suggesting a role of STAT4 in driving T-cell dependent GC B-cell maturation responses in murine lupus.

We found that circulating Tfh and circulating CD4+ T memory cells from patients secreted IL-21 and IFN-γ after stimulation. We next examined STAT4 activity these cells, after IFN-α and IL-12 stimulation in vitro, in comparison to cells from healthy controls. STAT4 phosphorylation, as an indicator of STAT4-mediated nuclear translocation, was more robust upon IFN-α than IL-12 stimulation, by contrast to canonical STAT4 phosphorylation driven by IL-12 in Th1 cells. Furthermore, the STAT4 phosphorylation correlated to greater disease activity (SLEDAI2K).

Conclusion: Our study indicates that as disease progresses in mice and humans with lupus, Tfh-cells and circulating CD4+ T memory cells are robustly responsive to STAT4-guided gene expression, which plays an important role in driving pathologic cytokine production in sustaining moderate and late stage disease activity.


Disclosure: X. Dong, None; F. Koumpouras, None; J. E. Craft, None; J. Weinstein, None.

To cite this abstract in AMA style:

Dong X, Koumpouras F, Craft JE, Weinstein J. STAT4 Activation By Type I Interferons Regulates Pathogenic IL-21 and IFN-γ in Lupus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/stat4-activation-by-type-i-interferons-regulates-pathogenic-il-21-and-ifn-%ce%b3-in-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/stat4-activation-by-type-i-interferons-regulates-pathogenic-il-21-and-ifn-%ce%b3-in-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology